Figure 6.
Figure 6. The defect in pDC differentiation is cell intrinsic. (A) BM from WT (Ly5B6; 2 × 106), IkL/L (Ly5B6; 5 × 106), or mixtures of WT:B6.Ly5SJL (1 × 106: 1 × 106) or IkL/L:B6.Ly5SJL (5 × 106:1 × 106) were used to reconstitute lethally-irradiated B6.Ly5SJL recipients. Recipients were analyzed 6 to 10 weeks after BM transfer. All plots are gated on small Ly5B6+CD11c-enriched cells. Numbers indicate the percentage of gated cells in each plot. One representative experiment of 4 is shown. (B) Ikaros expression in DC subsets. WT BM and splenic pDCs (CD11c+ B220+ 120G8+), and splenic CD11b+ cDCs (CD11c+ CD11b+120G8–) and CD8α+ cDCs (CD11c+CD8α+CD11b–120G8–) were analyzed by RT-PCR for their expression of Ikaros, Aiolos, and Helios. Whole WT thymocytes were used as a control. One representative experiment of 3 is shown.

The defect in pDC differentiation is cell intrinsic. (A) BM from WT (Ly5B6; 2 × 106), IkL/L (Ly5B6; 5 × 106), or mixtures of WT:B6.Ly5SJL (1 × 106: 1 × 106) or IkL/L:B6.Ly5SJL (5 × 106:1 × 106) were used to reconstitute lethally-irradiated B6.Ly5SJL recipients. Recipients were analyzed 6 to 10 weeks after BM transfer. All plots are gated on small Ly5B6+CD11c-enriched cells. Numbers indicate the percentage of gated cells in each plot. One representative experiment of 4 is shown. (B) Ikaros expression in DC subsets. WT BM and splenic pDCs (CD11c+ B220+ 120G8+), and splenic CD11b+ cDCs (CD11c+ CD11b+120G8) and CD8α+ cDCs (CD11c+CD8α+CD11b120G8) were analyzed by RT-PCR for their expression of Ikaros, Aiolos, and Helios. Whole WT thymocytes were used as a control. One representative experiment of 3 is shown.

Close Modal

or Create an Account

Close Modal
Close Modal